Evidence map›Paper›PMID 38345843›Full record

ArticleJMIR research protocols2024

Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial.

Ariel Siritorn Orasud, Mai Uchiyama, Ian Pagano, Erin Bantum

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03581357 (Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03581357 nacompletednot on this map

Mobile Mindfulness Meditation Intervention to Improve the Well-Being of Cancer Survivors

TypeinterventionalSponsorUniversity of HawaiiRan2019 to 2023Enrolled302ConditionsCancer, Other Than Non-melanoma Skin CancerArmsMobile Mindfulness Meditation, Mindfulness Coach
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ariel Siritorn Orasud *Cancer Prevention in the Pacific, University of Hawai'i Cancer Center, Honolulu, HI, United States.ORCID https://orcid.org/0000-0002-8796-3031
Mai UchiyamaCancer Prevention in the Pacific, University of Hawai'i Cancer Center, Honolulu, HI, United States.
Ian PaganoCancer Prevention in the Pacific, University of Hawai'i Cancer Center, Honolulu, HI, United States.ORCID https://orcid.org/0000-0002-6248-0113
Erin BantumCancer Prevention in the Pacific, University of Hawai'i Cancer Center, Honolulu, HI, United States.ORCID https://orcid.org/0000-0003-0239-4106
University of Hawaiʻi at Mānoa · US

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2M
Cancer Research Education, Advancement, Training and Empowerment (CREATE) in the PacificR25CA244073 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Joseph Keawe'aimoku Kaholokula, LENORA WM LOO · 2020 to 2026
$1.9M
NCI NIH HHS P30 CA071789NCI NIH HHS R25 CA244073
6 · The paper itself

Abstract

backgroundAnxiety- and cancer-related neuropathy are two persistent effects related to treatment for cancer. Mindfulness meditation has been used with substantial impact as a nonpharmacologic intervention to mitigate side and late effects of treatment. Mobile apps are ubiquitous for most of the general population, yet have a particular relevance for cancer survivors, given that physical and geographic limitations can be present.

objectiveThis study aims to describe an ongoing trial of the Mindfulness Coach mobile app for cancer survivors.

methodsIn this randomized waitlist controlled trial, cancer survivors experiencing anxiety- or cancer-related neuropathy (200 for neuropathy and 200 for anxiety) and who had finished primary cancer treatment were invited to participate. Data were collected at 3 time points regardless of randomization condition: baseline, 8 weeks, and 16 weeks. Both face-to-face and web-based recruitment strategies were used. The trial was opened for 2 separate primary outcomes (anxiety- or cancer-related neuropathy). The goal was not to compare these groups but to compare treatment and waitlist groups for each condition. In addition to evaluating the impact of mobile mindfulness on reported anxiety- or cancer-related neuropathy, other pain, fatigue, trauma, sleep, and satisfaction with the Mindfulness Coach app will also be assessed.

resultsOutcomes of the study are expected in early 2024.

conclusionsMindfulness meditation has become widely practiced, and the use of mobile technology has become ubiquitous. Finding ways to deliver mindfulness meditation to people who have been treated for cancer allows for the intervention to be accessible to a larger number of survivors. The results of this intervention could have implications for further understanding the impact of mindfulness meditation on 2 persistent side and late effects of treatment of cancer, namely anxiety- and cancer-related neuropathy.

trial registrationClinicalTrials.gov NCT03581357; https://ClinicalTrials.gov/study/NCT03581357. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/47745.

Indexed as

anxietycancercancer survivorshipclinical trialclinical trialscoachcoachingmeditationmental healthmHealthmindfulnessmindfulness meditationmobile healthneuropathyoncologyquality of liferandomizedRCTsurvivorsurvivorssurvivorshipwell-being

Identifiers

PMID38345843
PMCPMC10897800
OpenAlexW4391766845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.